CXCL9 is important for recruiting immune T cells into the brain and inducing an accumulation of the T cells to the areas of tachyzoite proliferation to prevent reactivation of chronic cerebral infection with Toxoplasma gondii

American Journal of Pathology

Volumn 185, Issue 2, 2015, Pages 314-324

  Ochiai, Eri ^a   Sa, Qila ^a   Brogli, Morgan ^a   Kudo, Tomoya ^a   Wang, Xisheng ^b   Dubey, Jitender P ^c   Suzuki, Yasuhiro ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR9 ANTAGONIST; CXCL9 CHEMOKINE; GAMMA INTERFERON; MESSENGER RNA; SULFADIAZINE; CXCL9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFECTION; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INTERFERON PRODUCTION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFECTION; SCID MOUSE; T LYMPHOCYTE; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; BAGG ALBINO MOUSE; BRAIN; CELL MOTION; CELL PROLIFERATION; CHRONIC DISEASE; ENCEPHALITIS; GENETICS; IMMUNOLOGY; PARASITOLOGY; PATHOLOGY; TOXOPLASMA;

ANIMALS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL9; CHRONIC DISEASE; ENCEPHALITIS; MICE; MICE, INBRED BALB C; MICE, SCID; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84922335608     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.10.003     Document Type: Article

References (58)

1. Suzuki Y, Orellana MA, Schreiber RD, Remington JS: Interferongamma: the major mediator of resistance against Toxoplasma gondii. Science 1988, 240:516-518
2. Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A: Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 1991, 146:286-292
3. Kang H, Remington JS, Suzuki Y: Decreased resistance of B celldeficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. J Immunol 2000, 164:2629-2634
4. Frenkel JK, Taylor DW: Toxoplasmosis in immunoglobulin M-suppressed mice. Infect Immun 1982, 38:360-367
5. Johnson LL, Sayles PC: Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice. Infect Immun 2002, 70:185-191
6. Denkers EY, Gazzinelli RT: Regulation and function of T-cellmediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 1998, 11:569-588
7. Boyer K, Marcinak J, McLeod R: Toxoplasma gondii (Toxoplasmosis). Edited by Long S, Pickering LK, Prober CG. Principles and Practice of Pediatric Infectious Diseases. ed 3. New York, Churchill Livingstone, 2007
8. Israelski DM, Remington JS: Toxoplasmosis in the non-AIDS immunocompromised host. Curr Clin Top Infect Dis 1993, 13: 322-356
9. Wong SY, Remington JS: Toxoplasmosis in the setting of AIDS. Edited by Broder S, Mergan TC Jr, Bolognesi D. Text Book of AIDS Medicine. Baltimore, Williams & Wikins, 1994, pp 223-257
10. Howe DK, Honore S, Derouin F, Sibley LD: Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol 1997, 35:1411-1414
11. Honore S, Couvelard A, Garin YJ, Bedel C, Henin D, Darde ML, Derouin F: [Genotyping of Toxoplasma gondii strains from immunocompromised patients] French. Pathol Biol (Paris) 2000, 48: 541-547
12. Ajzenberg D, Cogne N, Paris L, Bessieres MH, Thulliez P, Filisetti D, Pelloux H, Marty P, Darde ML: Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis 2002, 186:684-689
13. Suzuki Y, Joh K, Orellana MA, Conley FK, Remington JS: A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 1991, 74:732-739
14. Brown CR, Hunter CA, Estes RG, Beckmann E, Forman J, David C, Remington JS, McLeod R: Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 1995, 85:419-428
15. Suzuki Y, Conley FK, Remington JS: Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J Immunol 1989, 143:2045-2050
16. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 1992, 149: 175-180
17. Chao CC, Gekker G, Hu S, Peterson PK: Human microglial cell defense against Toxoplasma gondii. The role of cytokines. J Immunol 1994, 152:1246-1252
18. Chao CC, Hu S, Gekker G, Novick WJ Jr, Remington JS, Peterson PK: Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells. J Immunol 1993, 150:3404-3410
19. Peterson PK, Gekker G, Hu S, Chao CC: Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxidemediated mechanism. J Infect Dis 1995, 171:516-518
20. Daubener W, Remscheid C, Nockemann S, Pilz K, Seghrouchni S, Mackenzie C, Hadding U: Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha. Eur J Immunol 1996, 26:487-492
21. Halonen SK, Chiu F, Weiss LM: Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes. Infect Immun 1998, 66: 4989-4993
22. + T cells into the brain during chronic infection with Toxoplasma gondii. J Interferon Cytokine Res 2007, 27:329-338
23. Strack A, Asensio VC, Campbell IL, Schluter D, Deckert M: Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma. Acta Neuropathol 2002, 103:458-468
24. Sa Q, Ochiai E, Sengoku T, Wilson ME, Brogli M, Crutcher S, Michie SA, Xu B, Payne L, Wang X, Suzuki Y: VCAM-1/alpha4-beta1 integrin interaction is crucial for prompt recruitment of immune T cells into the brain during the early stage of reactivation of chronic infection with Toxoplasma gondii to prevent toxoplasmic encephalitis. Infect Immun 2014, 82:2826-2839
25. Luster AD: Chemokinese chemotactic cytokines that mediate inflammation. N Engl J Med 1998, 338:436-445
26. Baggiolini M, Dewald B, Moser B: Human chemokines: an update. Annu Rev Immunol 1997, 15:675-705
27. Wen X, Kudo T, Payne L, Wang X, Rodgers L, Suzuki Y: Predominant interferon-gamma-mediated expression of CXCL9, CXCL10, and CCL5 proteins in the brain during chronic infection with Toxoplasma gondii in BALB/c mice resistant to development of toxoplasmic encephalitis. J Interferon Cytokine Res 2010, 30:653-660
28. Strack A, Schluter D, Asensio VC, Campbell IL, Deckert M: Regulation of the kinetics of intracerebral chemokine gene expression in murine Toxoplasma encephalitis: impact of host genetic factors. Glia 2002, 40:372-377
29. Kang H, Suzuki Y: Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain. Infect Immun 2001, 69:2920-2927
30. Suzuki Y, Orellana MA, Wong SY, Conley FK, Remington JS: Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice. Infect Immun 1993, 61:2284-2288
31. Wang X, Claflin J, Kang H, Suzuki Y: Importance of CD8(+) Vbeta8(+) T Cells in IFN-gamma-mediated prevention of toxoplasmic encephalitis in genetically resistant BALB/c mice. J Interferon Cytokine Res 2005, 25:338-344
32. Wang X, Kang H, Kikuchi T, Suzuki Y: Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. Infect Immun 2004, 72: 4432-4438
33. Tannenbaum CS, Tubbs R, Armstrong D, Finke JH, Bukowski RM, Hamilton TA: The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol 1998, 161:927-932
34. Liu MT, Armstrong D, Hamilton TA, Lane TE: Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol 2001, 166:1790-1795
35. Ure DR, Lane TE, Liu MT, Rodriguez M: Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infection. Int Immunol 2005, 17:569-579
36. Suzuki Y, Rani S, Liesenfeld O, Kojima T, Lim S, Nguyen TA, Dalrymple SA, Murray R, Remington JS: Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect Immun 1997, 65:2339-2345
37. Kang H, Liesenfeld O, Remington JS, Claflin J, Wang X, Suzuki Y: TCR V beta 8+ T cells prevent development of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. J Immunol 2003, 170:4254-4259
38. Dubey JP: Isolation of Toxoplasma gondii from a naturally infected beef cow. J Parasitol 1992, 78:151-153
39. Singh J, Graniello C, Ni Y, Payne L, Sa Q, Hester J, Shelton BJ, Suzuki Y: Toxoplasma IgG and IgA, but not IgM, antibody titers increase in sera of immunocompetent mice in association with proliferation of tachyzoites in the brain during the chronic stage of infection. Microbes Infect 2010, 12:1252-1257
40. Hester J, Mullins J, Sa Q, Payne L, Mercier C, Cesbron-Delauw MF, Suzuki Y: Toxoplasma gondii antigens recognized by IgG antibodies differ between mice with and without active proliferation of tachyzoites in the brain during the chronic stage of infection. Infect Immun 2012, 80:3611-3620
41. Suzuki Y, Claflin J, Wang X, Lengi A, Kikuchi T: Microglia and macrophages as innate producers of interferon-gamma in the brain following infection with Toxoplasma gondii. Int J Parasitol 2005, 35: 83-90
42. Wang X, Suzuki Y: Microglia produce IFN-gamma independently from T cells during acute toxoplasmosis in the brain. J Interferon Cytokine Res 2007, 27:599-605
43. Farber JM: Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997, 61:246-257
44. Barnes DA, Huston M, Holmes R, Benveniste EN, Yong VW, Scholz P, Perez HD: Induction of RANTES expression by astrocytes and astrocytoma cell lines. J Neuroimmunol 1996, 71:207-214
45. Croitoru-Lamoury J, Guillemin GJ, Boussin FD, Mognetti B, Gigout LI, Cheret A, Vaslin B, Le Grand R, Brew BJ, Dormont D: Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 2003, 41:354-370
46. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B: Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996, 184:963-969
47. Piali L, Weber C, LaRosa G, Mackay CR, Springer TA, Clark-Lewis I, Moser B: The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur J Immunol 1998, 28: 961-972
48. Meiser A, Mueller A, Wise EL, McDonagh EM, Petit SJ, Saran N, Clark PC, Williams TJ, Pease JE: The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor. J Immunol 2008, 180: 6713-6724
49. Korniejewska A, McKnight AJ, Johnson Z, Watson ML, Ward SG: Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes. Immunology 2011, 132:503-515
50. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Hamilton TA, Armstrong DA, Lane TE: The CXC chemokines IP-10 and Mig are essential in host defense following infection with a neurotropic coronavirus. Adv Exp Med Biol 2001, 494:323-327
51. Thapa M, Welner RS, Pelayo R, Carr DJ: CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system. J Immunol 2008, 180: 1098-1106
52. Park MK, Amichay D, Love P, Wick E, Liao F, Grinberg A, Rabin RL, Zhang HH, Gebeyehu S, Wright TM, Iwasaki A, Weng Y, DeMartino JA, Elkins KL, Farber JM: The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J Immunol 2002, 169:1433-1443
53. Amichay D, Gazzinelli RT, Karupiah G, Moench TR, Sher A, Farber JM: Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-gamma with patterns of tissue expression that suggest nonredundant roles in vivo. J Immunol 1996, 157:4511-4520
54. Khan IA, MacLean JA, Lee FS, Casciotti L, DeHaan E, Schwartzman JD, Luster AD: IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 2000, 12:483-494
55. Cohen SB, Maurer KJ, Egan CE, Oghumu S, Satoskar AR, Denkers EY: CXCR3-dependent CD4(+) T cells are required to activate inflammatory monocytes for defense against intestinal infection. PLoS Pathog 2013, 9:e1003706
56. + T cells. Nature 2012, 486:545-548
57. Benevides L, Milanezi CM, Yamauchi LM, Benjamim CF, Silva JS, Silva NM: CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system. Am J Pathol 2008, 173:741-751
58. Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA, Colvin RA, Luster AD: Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci U S A 2008, 105:4814-4819